David T Hagerty

1PUBLICATIONS
0CO-AUTHORS
Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Nov 16, 2018
Randomised clinical trial: emricasan versus placebo significantly decreases ALT and caspase 3/7 activation in subjects with non-alcoholic fatty liver disease.

Mitchell Shiffman, Bradley Freilich, Raj Vuppalanchi

Pageof 1

Frequent Collaborators